The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro

Additional Metadata
Persistent URL	doi.org/10.1210/jc.2003-031344, hdl.handle.net/1765/55379
Journal	Journal of Clinical Endocrinology and Metabolism
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Hofland, L., van der Hoek, J., van Koetsveld, P., de Herder, W., Waaijers, M., Sprij-Mooij, D., … Lamberts, S. (2004). The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. Journal of Clinical Endocrinology and Metabolism, 89(4), 1577–1585. doi:10.1210/jc.2003-031344

Publication